Users of proteomics are in need of better data solutions, prompting many companies to rescue them with improved data analysis software.
Kinomics is illuminating drug development with an ever-growing toolbox of screening assays.
Researchers are having more fruitful searches for cancer genes by using SNP mapping.
Micro RNAs have been implicated in cancer. What does this mean for RNAi as a cancer treatment?
Functional proteomics gets a better shot at determining protein complex equilibria by using a multiplexed surface plasmon resonance optical biosensor.
Scientists doing functional genomics have never had so much variety in their molecular tool box.
Researchers seeking the "next generation" of therapeutics are taking novel—but undeniably risky approaches.
For liquid handling quality assurance, where you calibrate impacts what you measure.
Real-time PCR gets faster and smaller, and decades-old gel electrophoresis faces new competition with the advent of microfluidics
Decentralized J&J's single portal informatics platform allows far-flung research groups to connect and collaborate
Tanuja Koppal, PhD Editor in Chief Although we continually evaluate and evolve our editorial coverage to stay in tune with the informational needs of our readers, the New Year is always a time for new beginnings. As people take time to reflect on the past year and think about what they are doing and how they can do it better, we at Drug Discovery & Development are doing the same.
By combining two unrelated proteins researchers created a molecular switch that they say illustrates the potential of using such switches to "rewire the cellular circuitry" and could lead to the development of novel ways to treat disease.
William Porter Jr. At a Glance Title: Senior vice president, business development, Asia-Pacific Company: VDDI Pharmaceuticals, Brentwood, Tenn. Education: BS and MS, Michigan State University Background: Porter has more than 30 years experience in the biopharmaceutical industry, education, project management, and government relations.
Nanoliter and other types of liquid dispensers can speed testing, save money on compounds and reagents, and reduce error rates
Ted Agres Deputy Managing Editor, Washington Times With George W. Bush's re-election and with Republicans maintaining their hold on Congress, the pharmaceutical industry can expect free market policies to be favored should such issues as prescription price controls and drug reimportation re-emerge in 2005.